Harvard Apparatus Regenerative Technology, Inc. (HRGN)

SEC filing

Harvard Apparatus Regenerative Technology, Inc.

HRGN · CIK 1563665

4 · Sep 25, 2026 · Director, CEO He Junli bought 368.63K shares at $1.07/share ($394.5K); converted 1.40M shares

Director, CEO He Junli bought 368.63K shares at $1.07/share ($394.5K); converted 1.40M shares

FORM 4

xslF345X06/rdgdoc.xmlSEC.gov

Graphics and non-inline formats (not embedded below).